Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of beta-blockers on exercise performance in uncomplicated hypertension
2009-011156-21Phase 3Active
- Sponsor
- Centro Cardiologico Monzino
- Start
- Sep 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bisoprolol and atenolol in essential hypertension and hypertension (HTN) (3 arms), sponsored by Centro Cardiologico Monzino. Primary endpoints: Peak VO2 change, Exercise capacity and 1 more. Started Sep 2011; status: active.
02
Drugs
bisoprololatenolol
03
Conditions
essential hypertensionhypertension (HTN)
Beyond the preview
Go deeper on 2009-011156-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011156-21.